Project Grant R01DK140328
- This $163,511 Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research investigating the mechanisms by which dietary fiber supplementation prevents obesity and reduces hypothalamic inflammation. The research will be conducted at the University of Illinois in Chicago from September 1, 2025, through May 31, 2030. The project focuses on...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $2.64 million to the University of Massachusetts Medical School under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year research project running from September 1, 2025, through August 31, 2029. The research investigates novel mitochondrial mechanisms underlying obesity pathogenesis, with a focus on understanding how...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Duke University a $241,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to study the regulation of metabolic diseases by the human commensal bacterium Clostridium immunis. The overarching goal is to determine the mechanism by which an exopolysaccharide (EPS) secreted by C. immunis decreases visceral adiposity, a key risk factor for type 2 diabetes and...
- The federal Project Grant award R15DK136098, "SEX DIFFERENCES IN HEDONIC FEEDING: THE ROLE OF THE GUT MICROBIOME," is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $416,456 award to Furman University aims to characterize sex differences in the gut microbiome and their impact on hedonic feeding, or food intake driven by pleasure rather than...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Boston Children's Hospital a $168,900 project grant effective July 15, 2025, through May 31, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates the mechanistic pathways by which Blautia species—commensal bacteria—activate enteroendocrine cells to produce satiety hormones and support gastrointestinal...
- Summary of Federal Grant Award The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Beckman Research Institute of the City of Hope $140,116.00 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) via Project Grant on September 15, 2025, with completion targeted for July 31, 2028. This research initiative investigates gut-fat crosstalk mechanisms in metabolic regulation, specifically examining how intestinal mammalian...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Vermont & State Agricultural College a $487,590 Project Grant effective July 1, 2025, through April 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research initiative focuses on elucidating the mechanisms by which tryptophan-producing bacteria modulate serotonin signaling in both the gastrointestinal...
- Summary The University of Colorado-Denver received a $129,619 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through May 31, 2030. The award funds basic research investigating the interactions between the gut microbiome, intestinal development, and metabolic health outcomes in offspring experiencing fetal growth...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Leland Stanford Junior University a Project Grant of $796,068 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective February 1, 2026, through January 31, 2031. This five-year research initiative investigates the role of the beta-hydroxybutyrate (BHB) shunt—a recently discovered third metabolic pathway for BHB—in regulating...
- Federal Project Grant Award Summary Harvard College's Office for Sponsored Programs received a $421,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award supports fundamental research investigating how the human gut microbiome contributes to metabolic health and how lifestyle factors such as diet, exercise, and social contact...
DEFINING THE QUANTITATIVE FUNCTIONAL MECHANISMS THAT UNDERLY GUT MICROBIOME-DIET INTERACTIONS CONTRIBUTING TO HUMAN ENERGY BALANCE - PROJECT SUMMARY THE OBESITY EPIDEMIC CONTINUES TO AFFLICT POPULATIONS GLOBALLY. THE LITERATURE IS REPLETE WITH OBSERVATIONAL STUDIES PURPORTING A ROLE OF THE GUT MICROBIOME IN BODY WEIGHT REGULATION. THE MAIN GAP IN THE DEVELOPMENT OF MICROBIOME-TARGETED THERAPEUTICS TO TREAT OBESITY IS A DEEP UNDERSTANDING OF THE CAUSAL MECHANISMS BY WHICH MICROBES IMPACT ENERGY BALANCE IN HUMANS. IN A FIRST OF ITS KIND STUDY, WE IMPLEMENTED A QUANTITATIVE BIOENERGETICS PARADIGM IN WHICH HUMAN ENERGY BALANCE WAS DEEPLY AND PRECISELY PHENOTYPED (ENERGY INTAKE, EXPENDITURE AND FECAL ENERGY LOSS) DURING AN INPATIENT RANDOMIZED CONTROLLED CROSSOVER FEEDING STUDY. WE USED DIETS THAT DELIVERED MINIMAL (WESTERN DIET; WD) VERSUS HIGH (MICROBIOME ENHANCER DIET; MBD) AMOUNTS OF MICROBIOTA FERMENTABLE DIETARY SUBSTRATES TO THE COLON TO REPROGRAM THE GUT MICROBIOME WITHIN INDIVIDUALS. WE UNCOVERED DIET-HOST-MICROBE INTERACTIONS THAT IMPACTED HUMAN ENERGY BALANCE VIA INCREASED FECAL ENERGY LOSS AND THUS, LOWER METABOLIZABLE ENERGY (ME) THAT WAS DUE IN PART TO AN INCREASE IN MICROBIAL BIOMASS ON THE MBD AS COMPARED TO THE WD. TO ADVANCE THIS WORK, WE NEED TO UNDERSTAND THE QUANTITATIVE AND FUNCTIONAL MECHANISMS BY WHICH THE GUT MICROBIOME IMPACTS ME WHEN EXPOSED TO DIFFERENT DIETS. WE PROPOSE TWO AIMS TO ACCOMPLISH THIS. IN AIM 1A, WE WILL DETERMINE THE AMOUNT OF FECAL ENERGY LOSS THAT IS DUE TO SHUNTING OF ENERGY FROM THE HUMAN DIET TOWARDS BIOMASS EXPANSION (AND THUS AWAY FROM THE HOST) TO TEST THE HYPOTHESIS THAT THE DIETARY ENERGY DIVERTED FROM HOST TOWARDS BIOMASS EXPANSION IS LARGE ENOUGH TO PROMOTE LOWER ME (NET NEGATIVE ENERGY BALANCE) ON THE MBD VS. THE WD. IN AIM 1B, WE WILL PERFORM ABSOLUTE QUANTIFICATION OF MICROBIAL SPECIES TO DETERMINE WHICH ONES ARE THE DOMINANT PLAYERS IN BIOMASS EXPANSION AND THEIR PROPORTIONAL CONTRIBUTION TO FECAL BIOMASS ENERGY. IN AIM 2A, WE WILL IMPLEMENT A NOVEL INTEGRATED MULTI-OMICS WORKFLOW AIMED AT DETERMINING MICROBIAL FUNCTIONS AND SUBSTRATE PREFERENCES IN VIVO. THESE DATA WILL TELL US WHAT THE MICROBES "EAT", WHICH SPECIFIC SPECIES COMPETE FOR THE SAME DIETARY SUBSTRATES, AND THE ASSOCIATED FUNCTIONS OF THE MICROBIAL COMMUNITY WHEN SPECIFIC DIETARY SUBSTRATES ARE AVAILABLE. THESE DATA WILL BE VALIDATED IN AIM 2B BY PERFORMING EX VIVO EXPERIMENTS TO CHANGE THE ABSOLUTE ABUNDANCE OF SPECIFIC MICROBES THAT CONTRIBUTE MOST TO BIOMASS BY ADDITION OF THE PREFERRED SUBSTRATES OF THOSE MICROBES. THE OVERALL OUTCOME OF THIS PROJECT IS THAT WE WILL HAVE AN UNPRECEDENTED UNDERSTANDING OF THE QUANTITATIVE MICROBIAL MECHANISMS THAT DRIVE HUMAN ENERGY BALANCE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 6/27/25 | ||
| Not listed | $568.1k | 4/15/25 | ||
| Not listed | $568.1k | 4/15/25 | ||
| Not listed | $0 | 7/16/24 | ||
| Not listed | $0 | 7/16/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
2052776UCSDS | University Of California, San Diego | Project Grant R01DK140328 | $283.0k | 12/18/24 |